Clearside Biomedical Inc. (NASDAQ: CLSD) stock closed at 1.02 per share at the end of the most recent trading day (a 0.99% change compared to the prior day closing price) with a volume of 68.34K shares and market capitalization of 60.75M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 33 people. Clearside Biomedical Inc. CEO is George Lasezkay.

The one-year performance of Clearside Biomedical Inc. stock is -57.68%, while year-to-date (YTD) performance is -8.93%. CLSD stock has a five-year performance of -91.32%. Its 52-week range is between 0.93 and 2.61, which gives CLSD stock a 52-week price range ratio of 3.57%

Clearside Biomedical Inc. currently has a PE ratio of -27.30, a price-to-book (PB) ratio of 5.32, a price-to-sale (PS) ratio of 97.20, a price to cashflow ratio of 399.40, a PEG ratio of 2.32, a ROA of -11.60%, a ROC of -24.36% and a ROE of -27.18%. The company’s profit margin is -26.16%, its EBITDA margin is -15.40%, and its revenue ttm is $997.00 Thousand , which makes it $0.02 revenue per share.

Of the last four earnings reports from Clearside Biomedical Inc., there were 0 positive earnings surprise and 3 negative earnings surprise. The company has EPS estimate of $-0.14 for the next earnings report. Clearside Biomedical Inc.’s next earnings report date is 10th May 2023.

The consensus rating of Wall Street analysts for Clearside Biomedical Inc. is Strong Buy (1.2), with a target price of $6.25, which is +531.31% compared to the current price. The earnings rating for Clearside Biomedical Inc. stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Clearside Biomedical Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Clearside Biomedical Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 12.57, ATR14 : 0.10, CCI20 : -79.57, Chaikin Money Flow : -0.40, MACD : -0.09, Money Flow Index : 19.03, ROC : -20.31, RSI : 37.83, STOCH (14,3) : 22.50, STOCH RSI : 1.00, UO : 38.13, Williams %R : -77.50), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Clearside Biomedical Inc. in the last 12-months were: Charles A. Deignan (Option Excercise at a value of $9 454), Clay B. Thorp (Buy at a value of $14 266), Nancy J. Hutson (Buy at a value of $39 900), Thomas Ciulla (Sold 2 170 shares of value $3 515 )